Publikationen Purvanov

Publikationen Dr. Vladimir Purvanov

Ruef N, Martínez Magdaleno J, Ficht X, Purvanov V, Palayret M, Wissmann S, Pfenninger P, Stolp B, Thelen F, Barreto de Albuquerque J, Germann P, Sharpe J, Abe J, Legler DF, Stein JV. 2023. Exocrine gland-resident memory CD8+ T cells use mechanosensing for tissue surveillance. Sci Immunol Dec 22;8(90):eadd5724. doi: 10.1126/sciimmunol.add5724. Epub 2023 Dec 22.
Artinger M, Gerken OJ, Purvanov V, Legler DF. 2022. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration. Front Immunol 13:913366. doi: 10.3389/fimmu.2022.913366.
Uetz-von Allmen E, Samson GPB, Purvanov V, Maeda T, Legler DF. 2021. CAL-1 as cellular model system to study CCR7-guided human dendritic cell migration. Front Immunol Sep 16;12:702453. doi: 10.3389/fimmu.2021.702453.
James KD, Legler DF, Purvanov V, Ohigashi I, Takahama Y, Parnell SM, White AJ, Jenkinson WE, Anderson G. 2021. Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus. Blood Adv Jan 12;5(1):99-112. doi: 10.1182/bloodadvances.2020003192.
Matti C, D'Uonnolo G, Artinger M, Melgrati S, Salnikov A, Thelen S, Purvanov V, Strobel TD, Spannagel L, Thelen M, Legler DF. 2020. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4. J Leukoc Biol Jun;107(6):1137-1154. doi: 10.1002/JLB.2MA0420-295RRR.
Laufer JM, Hauser MA, Kindinger I, Purvanov V, Pauli A, Legler DF. 2019. Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation. Cell Rep 29(4):995-1009. e6, October 22, 2019.
Jakobs BD, Spannagel L, Purvanov V, Uetz-von Allmen E, Matti C, Legler DF. 2019. Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7. Int J Mol Sci Int J Mol Sci. 2019 May 27;20(10). pii: E2597. doi: 10.3390/ijms20102597. Repository
Purvanov V, Matti C, Samson GPB, Kindinger I, Legler DF. 2018. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions. Int J Mol Sci Dec 4;19(12). pii: E3876. doi: 10.3390/ijms19123876.
Nyffeler J, Chovancova P, Dolde X, Holzer AK, Purvanov V, Kindinger I, Kerins A, Higton D, Silvester S, van Vugt-Lussenburg BMA, Glaab E, van der Burg B, Maclennan R, Legler DF, Leist M. 2018. A structure-activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins. Arch Toxicol Mar;92(3):1225-1247. doi: 10.1007/s00204-017-2125-4. Epub 2017 Nov 21.
Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Chaucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B. 2017. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4. FASEB J 31:3084-3097.
Legler DF, Matti C, Laufer JM, Jakobs BD, Purvanov V, Uetz-von Allmen E, Thelen M. 2017. Modulation of chemokine receptor function by cholesterol: new prospects for pharmacological intervention. Mol Pharmacol 91(4):331-338.
Lüchtenborg AM, Purvanov V, Melnik BS, Becker S, Katanaev VL. 2015. Mode of interaction of the Gαo subunit of heterotrimeric G proteins with the GoLoco1 motif of Drosophila Pins is determined by guanine nucleotides. Biosci Rep Oct 20. pii: BSR20150201. [Epub ahead of print].
Purvanov V, Holst M, Khan J, Baarlink C, Grosse R. 2014. G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion. ELIFE Jun 20;3. doi: 10.7554/eLife.02786.
Koval A, Purvanov V, Egger-Adam D, Katanaev VL. 2011. Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets. Biochem Pharmacol 82(10):1311-1319.
Purvanov V, Koval A, Katanaev VL. 2010. A direct and functional interaction between Go and Rab5 during G protein-coupled receptor signaling. Sci Signal 3(136):ra65. doi: 10.1126/scisignal.2000877.
Koval A, Kopein D, Purvanov V, Katanaev VL. 2010. Europium-labeled GTP as a general nonradioactive substitute for [(35)S]GTPgammaS in high-throughput G protein studies. Anal Biochem 397(2):202-207.
Purvanov V, Fetzner S. 2005. Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity. Curr Microbiol 50(4):217-222.
Bonin I, Martins BM, Purvanov V, Fetzner S, Huber R, Dobbek H. 2004. Active site geometry and substrate recognition of the molybdenum hydroxylase quinoline 2-oxidoreductase. Structure 2(8):1425-1435.